Delivery Order SPE2DR25D2014-SPE2DR26FA7F9
Award Date 2/26/26
Potential Completion Date 2/27/26
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $2,382.66 delivery order to AmerisourceBergen Drug Corp on February 26, 2026, for ENGERIX-B 20 MCG/ML vaccine supply. The order is issued under the parent Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. This IDC serves as a global pharmaceutical support vehicle enabling supply of pharmaceutical products and medical supplies to support military healthcare programs worldwide,...
- The Defense Logistics Agency issued a $15,081.88 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for ENGERIX-B 20 MCG/ML vaccine supply. The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical supply vehicle valued at up to $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is February 6, 2026. Pricing is firm fixed price with no...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 20, 2026, with a ceiling value of $22,437.48 for ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML vaccine supply. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026. This vehicle provides comprehensive global pharmaceutical support and medical supply delivery to military healthcare programs. Place of performance is...
- The Defense Logistics Agency issued a $1,074.40 delivery order to AmerisourceBergen Drug Corp on February 26, 2026, for ENGERIX-B 20 MCG/ML vaccine supply. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp is a for-profit pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, where performance will occur. The order is firm fixed price with an ultimate...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 5, 2026, for ENGERIX-B 20 MCG/ML vaccine with a ceiling value of $3,033.27. The order was placed against the parent IDC with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026 supporting military healthcare programs worldwide. Place of performance is Conshohocken, Pennsylvania. The delivery order uses firm fixed...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 23, 2026, for ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML vaccine with a ceiling value of $17,259.60 under firm fixed-price terms. Place of performance is Conshohocken, PA. The order is issued under the parent DLA Troop Support Medical Indefinite Delivery Contract valued at $999,999,999.00 through December 2026, which covers pharmaceutical products and medical supplies to support military healthcare programs...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 12, 2026, for Engerix-B 20 mcg/ml vaccine with a ceiling value of $4,183.54. Place of performance is Conshohocken, PA. The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, which provides a comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally through December 2026. Ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $23,145.08 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for ENGERIX-B 20 MCG/ML vaccine supply, with a ceiling value of $2,567.38. This firm fixed-price delivery order, with an ultimate completion date of April 25, 2025, represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply framework. The contract was competitively awarded with no set-aside designation and will be performed at the company's corporate office...
- On January 28, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,348.12 to Amerisourcebergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine, with completion scheduled for January 29, 2026. The contract employs firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent...